Sign inJoin waitlistJoin the waitlist

CB

Carolyn Britten

Physician · MUSC PHYSICIANS

Credentials: · ·

History

MUSC PHYSICIANS · UNIVERSITY MEDICAL ASSOCIATES
Present

Hematology and Medical Oncology
1995–1998
Internal Medicine
1992–1995
Medical School
1988–1992

Research

Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
Journal of Clinical Oncology · 2001 · 860 citations
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Journal of Clinical Oncology · 2017 · 485 citations
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial
The Lancet Oncology · 2018 · 469 citations

ER
Eric Rowinsky
9 papers
Gail Eckhardt
8 papers
Richard Finn
7 papers
DH
Daniel Von Hoff
6 papers
Dennis Slamon
6 papers
Zev Wainberg
5 papers
AP
Amita Patnaik
4 papers
AT
Anthony Tolcher
4 papers
Manuel Medina
4 papers · 4 as a fellow
MV
Miguel Villalona-Calero
4 papers
Ronald Busuttil
4 papers
GW
Geoffrey Weiss
3 papers